PharmEasy In Talks For Raising $250 Mn Ahead Of INR 6,250 Cr IPO
E-pharmacy unicorn PharmEasy is in talks with private equity (PE) investors to raise debt to the tune of $250 Mn in a bridge financing round.
Stay updated with breaking news from Ascent Wellness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
E-pharmacy unicorn PharmEasy is in talks with private equity (PE) investors to raise debt to the tune of $250 Mn in a bridge financing round.
Author Bio Sushree is a new member of the Fool family, keen on writing about the cannabis and healthcare sector and also has five years of experience writing on real estate, consumer sector, and macroeconomic topics. She holds a bachelor’s degree in business management, specializing in finance, and also a CFA Level 2 candidate. Being a fitness enthusiast and a creative person, when she isn't writing, she is either kick-boxing or painting. Innovative Industrial Properties (NYSE:IIPR) is not a pure-play cannabis company. It is an REIT (real estate investment trust) th...